Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Targeted Therapy (Antibody-Drug Conjugate) (21)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Brentuximab Vedotin	ADC	Hematologic
Molecule Brentuximab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Gemtuzumab Ozogamicin	ADC	Hematologic
Molecule Gemtuzumab Ozogamicin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Inotuzumab Ozogamicin	ADC	Hematologic
Molecule Inotuzumab Ozogamicin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Polatuzumab Vedotin	ADC	Hematologic
Molecule Polatuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Loncastuximab Tesirine	ADC	Hematologic
Molecule Loncastuximab Tesirine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Belantamab Mafodotin	ADC	Hematologic
Molecule Belantamab Mafodotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Tafasitamab	ADC	Hematologic
Molecule Tafasitamab Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Naratuximab Emtansine	ADC	Hematologic
Molecule Naratuximab Emtansine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Sacituzumab Govitecan	ADC	Solid Tumour
Molecule Sacituzumab Govitecan Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Enfortumab Vedotin	ADC	Solid Tumour
Molecule Enfortumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Tisotumab Vedotin	ADC	Solid Tumour
Molecule Tisotumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Mirvetuximab Soravtansine	ADC	Solid Tumour
Molecule Mirvetuximab Soravtansine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC

Brentuximab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Gemtuzumab Ozogamicin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Inotuzumab Ozogamicin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Polatuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Loncastuximab Tesirine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Belantamab Mafodotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Tafasitamab Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Naratuximab Emtansine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Sacituzumab Govitecan Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Enfortumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Tisotumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Mirvetuximab Soravtansine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC

‹ 1 2 ›

Product Range

Company

Global Network

Products

Brentuximab Vedotin

Gemtuzumab Ozogamicin

Inotuzumab Ozogamicin

Polatuzumab Vedotin

Loncastuximab Tesirine

Belantamab Mafodotin

Tafasitamab

Naratuximab Emtansine

Sacituzumab Govitecan

Enfortumab Vedotin

Tisotumab Vedotin

Mirvetuximab Soravtansine